Detalhe da pesquisa
1.
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon.
Gut
; 65(3): 456-64, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645662
2.
Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice.
Am J Physiol Gastrointest Liver Physiol
; 307(9): G871-82, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25234043
3.
Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitis.
Am J Physiol Gastrointest Liver Physiol
; 303(2): G220-7, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22595989
4.
African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.
J Immunol
; 184(12): 7001-9, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20483768
5.
The Crohn's disease: associated ATG16L1 variant and Salmonella invasion.
BMJ Open
; 3(6)2013 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23794574
6.
TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions.
PLoS One
; 6(10): e26352, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031828
7.
Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors.
ACS Med Chem Lett
; 2(1): 34-8, 2011 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900252
8.
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.
ACS Med Chem Lett
; 2(10): 774-9, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900266